Responses
Other responses
Jump to comment:
- Published on: 22 March 2016
- Published on: 22 March 2016
- Published on: 22 March 2016
- Published on: 22 March 2016
- Published on: 22 March 2016
- Published on: 22 March 2016Treatment for presumed Ocular tuberculosisShow More
Dear Editor
I was delighted to read Dr Okada’s reply to my letter.[1] At the risk of transgressing from the point of the original article [2] that dealt with a novel technique to administer triamcinolone to a wide group of patients with uveitis, I would like to reply:
1. The WHO guidelines are indeed silent on the treatment of latent tuberculosis which can be defined as merely positive mantoux tests w...
Conflict of Interest:
None declared. - Published on: 22 March 2016Much Ado About Periocular CorticosteroidsShow More
Dear Editor
I thank Dr Okada et al for replying to my letter to the editor regarding their article "Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis".[1] While speculating that the cause of the lack of therapeutic response to sub-tenon’s corticosteroids may be because of placement at a site relatively far from the target zone, I had quoted only the article by Freeman et al...
Conflict of Interest:
None declared. - Published on: 22 March 2016Trans-Tenon's retrobulbar triamcinolone infusions in uveitisShow More
Dear Editor
We appreciate the interest and many comments we have received regarding our recent article on "Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis."[1]
In reply to the comments by Dr Vedantham, we acknowledge the paucity of experimental data to actually prove that accurate placement of corticosteroids into the sub-Tenon's space provides good drug penetration into the ey...
Conflict of Interest:
None declared. - Published on: 22 March 2016Comments on periocular corticosteroid therapyShow More
Dear Editor
I read with great interest the article by Okada et al,[1] reporting the efficacy and complications of trans-tenon’s retrobulbar infusion of triamcinolone acetonide for posterior uveitic inflammation. The authors have to be commended for the excellent description of this novel technique.
The efficacy of various modalities of corticosteroid injection has always been a matter of debate w...
Conflict of Interest:
None declared. - Published on: 22 March 2016Trans-Tenons Triamcinolone and PretreatmentShow More
Dear Editor
I read with great interest the article by Okada et al.[1] I would like to make the following comments:
(1) The authors describe three patients of tubercular uveitis who are being treated with isoniazid and rifampicin for a month prior to their treatment with trans-tenons triamcinolone. However, current WHO guidelines recommend an initial phase of 2 months with four drugs (iso...Conflict of Interest:
None declared.